EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Avoiding the use of long-term parenteral support in patients without intestinal failure: A position paper from the European Society of Clinical Nutrition & Metabolism, the European Society of Neurogastroenterology and Motility and the Rome Foundation for Disorders of Gut–Brain Interaction

S Lal, P Paine, J Tack, Q Aziz, R Barazzoni, C Cuerda, P Jeppesen, F Joly, G Lamprecht, M Mundi, S Schneider, K Szczepanek und 4 weitere

Clinical Nutrition · 2024-09 · 43 (9) · 2279-2282

DOI: 10.1016/j.clnu.2024.05.027 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Clinical Nutrition, 2024-09. Verfasst von S Lal und 15 weiteren Autor:innen. Beteiligte Einrichtung: National Intestinal Failure Reference Centre, Northern Care Alliance and University of Manchester, Stott Lane, Salford, Manchester, M6 8HD, UK. Elect…. Hauptthemen laut MEDLINE: Parenteral Nutrition, Home. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The role of long-term parenteral support in patients with underlying benign conditions who do not have intestinal failure (IF) is contentious, not least since there are clear benefits in utilising the oral or enteral route for nutritional support. Furthermore, the risks of long-term home parenteral nutrition (HPN) are significant, with significant impacts on morbidity and mortality. There has, however, been a recent upsurge of the use of HPN in patients with conditions such as gastro-intestinal neuromuscular disorders, opioid bowel dysfunction, disorders of gut-brain interaction and possibly eating disorders, who do not have IF. As a result, the European Society of Clinical Nutrition and Metabolism (ESPEN), the European Society of Neuro-gastroenterology and Motility (ESNM) and the Rome Foundation for Disorders of Gut Brain Interaction felt that a position statement is required to clarify - and hopefully reduce the potential for harm associated with - the use of long-term parenteral support in patients without IF. Consensus opinion is that HPN should not be prescribed for patients without IF, where the oral and/or enteral route can be utilised. On the rare occasions that PN commencement is required to treat life-threatening malnutrition in conditions such as those listed above, it should only be prescribed for a time-limited period to achieve nutritional safety, while the wider multi-disciplinary team focus on more appropriate biopsychosocial holistic and rehabilitative approaches to manage the patient's primary underlying condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parenteral Nutrition, HomeHumansBrain-Gut AxisParenteral NutritionIntestinal FailureConsensusEuropeSocieties, Medical

Stichwörter der Autor:innen

Chronic intestinal failureDisorders of gut–brain interactionGastro-intestinal neuromuscular disordersHome parenteral nutritionOpioid bowel dysfunctionParenteral nutrition

Autor:innen und Institutionen

  • National Intestinal Failure Reference Centre, Northern Care Alliance and University of Manchester, Stott Lane, Salford, Manchester, M6 8HD, UK. Electronic address: simon.lal@nca.nhs.uk.
  • Department of Gastroenterology, Northern Care Alliance and University of Manchester, Stott Lane, Salford, Manchester, M6 8HD, UK.
  • Translational Research Center for Gastrointestinal Disorders, KU Leuven, Herestraat 49, 3000, Leuven, Belgium; Rome Foundation, Raleigh, North Caroline, USA.
  • Blizard Institute, Wingate Institute for Neurogastroenterology, Centre for Neuroscience, Surgery and Trauma, Queen Mary University of London, London, UK.
  • Department of Medical, Surgical and Health Sciences, University of Trieste, Italy.
  • Departamento de Medicina, Universidad Complutense de Madrid, Nutrition Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Zitieren

APA

Lal, S., Paine, P., Tack, J., Aziz, Q., Barazzoni, R., Cuerda, C., Jeppesen, P., Joly, F., Lamprecht, G., Mundi, M., Schneider, S., Szczepanek, K., Van Gossum, A., Wanten, G., Vanuytsel, T., & Pironi, L. (2024). Avoiding the use of long-term parenteral support in patients without intestinal failure: A position paper from the European Society of Clinical Nutrition & Metabolism, the European Society of Neurogastroenterology and Motility and the Rome Foundation for Disorders of Gut–Brain Interaction. Clinical Nutrition, 43(9), 2279-2282. https://doi.org/10.1016/j.clnu.2024.05.027

Vancouver

Lal S, Paine P, Tack J, Aziz Q, Barazzoni R, Cuerda C, et al. Avoiding the use of long-term parenteral support in patients without intestinal failure: A position paper from the European Society of Clinical Nutrition & Metabolism, the European Society of Neurogastroenterology and Motility and the Rome Foundation for Disorders of Gut–Brain Interaction. Clinical Nutrition. 2024;43(9):2279-2282. doi:10.1016/j.clnu.2024.05.027

BibTeX
@article{Lal2024,
  author = {Lal, S and Paine, P and Tack, J and Aziz, Q and Barazzoni, R and Cuerda, C and Jeppesen, P and Joly, F and Lamprecht, G and Mundi, M and Schneider, S and Szczepanek, K and Van Gossum, A and Wanten, G and Vanuytsel, T and Pironi, L},
  title = {Avoiding the use of long-term parenteral support in patients without intestinal failure: A position paper from the European Society of Clinical Nutrition & Metabolism, the European Society of Neurogastroenterology and Motility and the Rome Foundation for Disorders of Gut–Brain Interaction},
  journal = {Clinical Nutrition},
  year = {2024},
  volume = {43},
  number = {9},
  pages = {2279--2282},
  doi = {10.1016/j.clnu.2024.05.027}
}
Kostenlos starten →